MDMA effects consistent across laboratories |
| |
Authors: | Matthew G. Kirkpatrick Matthew J. Baggott John E. Mendelson Gantt P. Galloway Matthias E. Liechti Cédric M. Hysek Harriet de Wit |
| |
Affiliation: | 1. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S. Maryland Ave., MC 3077, Chicago, IL, 60637, USA 2. Addiction & Pharmacology Research Laboratory, California Pacific Medical Center, San Francisco, CA, USA 3. Division of Clinical Pharmacology and Toxicology, University Hospital and University of Basel, Basel, Switzerland
|
| |
Abstract: | Rationale Several laboratories have conducted placebo-controlled drug challenge studies with 3,4-methylenedioxymethamphetamine (MDMA), providing a unique source of data to examine the reliability of the acute effects of the drug across subject samples and settings. We examined the subjective and physiological responses to the drug across three different laboratories and investigated the influence of prior MDMA use. Methods Overall, 220 healthy volunteers with varying levels of previous MDMA experience participated in laboratory-based studies in which they received placebo or MDMA orally (1.5 mg/kg or 125-mg fixed dose) under double-blind conditions. Cardiovascular and subjective effects were assessed before and repeatedly after drug administration. The studies were conducted independently by investigators in Basel, San Francisco, and Chicago. Results Despite methodological differences between the studies and differences in the subjects’ drug use histories, MDMA produced very similar cardiovascular and subjective effects across the sites. The participants’ prior use of MDMA was inversely related to feeling “Any Drug Effect” only at sites testing more experienced users. Conclusions These data indicate that the pharmacological effects of MDMA are robust and highly reproducible across settings. There was also modest evidence for tolerance to the effects of MDMA in regular users. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|